发明名称 CERAMIDE KINASE MODULATION
摘要 A compound of formula (I) wherein R<SUB>1</SUB> is a straight chain, branched or cyclic aliphatic, aromatic or heterocyclyl group comprising at least 8 carbon atoms, e.g. 8 to 22, R<SUB>2</SUB> is a straight chain, branched or cyclic aliphatic, aromatic or heterocyclic group comprising from 1 to 12 carbon atoms, and ring A is heterocycyl, fused with the phenyl ring to which ring A is attached comprising 5 or 6 ring members, and 1 to 4 heteroatoms selected from N,S,O; wherein certain compounds are excluded by proviso and the use of such compounds without proviso as pharmaceuticals in disorders which are mediated by ceramide kinase.
申请公布号 WO2007112914(A2) 申请公布日期 2007.10.11
申请号 WO2007EP02765 申请日期 2007.03.28
申请人 NOVARTIS AG;NOVARTIS PHARMA GMBH;BORNANCIN, FREDERIC;OBERHAUSER, BERNDT 发明人 BORNANCIN, FREDERIC;OBERHAUSER, BERNDT
分类号 主分类号
代理机构 代理人
主权项
地址